Every January tens of thousands of technology fans from across the world flock to the bright lights of Las Vegas for the annual Consumer Electronics Show (CES). Some of the biggest digital health and MedTech announcements of the year are made at CES and this year’s show was no exception, with wearable health tech products particularly popular.
At Bond Digital Health we believe the future of lateral flow is digital and we see it as our mission to help the sector fully realise the huge potential of this technology. Bond’s innovative 'software for medical devices supports POC assay developers and lateral flow reader manufactures by providing a digital platform for test data to be collected, analysed and displayed.
We are now moving into a new generation of lateral flow tests, one in which data is an integral part, and that is why we believe Bond Digital Health is perfectly placed to become a key player in the market; our technology enhances lateral flow tests transforming them into digitally connected assays that are part of a larger ecosystem improving decision making at the point-of-care.
A team from Bond is traveling to San Diego to exhibit at a key industry event - the Advanced Lateral Flow Course. We will be demonstrating how our end-to-end digital platform can help lateral flow assay developers and lateral flow reader device manufacturers leverage cloud technology to elevate their diagnostic tests to a whole new level.
Welsh life sciences technology company Bond Digital Health has created two new job roles after receiving more than a quarter or a million pounds in funding. The company, based at the Life Sciences Hub in Cardiff, has hired Edryd Sharp as head of product design and Phil Cooley as quality assurance manager.